Newsroom

Sorted by: Latest

-

IQExit Appoints Former Schwab, Fidelity and Ameriprise Executive Glenn Flego to Board

WILMINGTON, N.C.--(BUSINESS WIRE)--IQExit appoints former Schwab, Fidelity and Ameriprise executive Glenn Flego to its Board to advance early exit intelligence for trusted advisors....
-

CARR Investors Have Opportunity to Join Carrier Global Corporation Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--CARR Investors Have Opportunity to Join Carrier Global Corporation Fraud Investigation with SBS Law...
-

INIO Investors Have Opportunity to Join Innio N.V. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--INIO Investors Have Opportunity to Join Innio N.V. Fraud Investigation with SBS Law...
-

ROL Investors Have Opportunity to Join Rollins, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--ROL Investors Have Opportunity to Join Rollins, Inc. Fraud Investigation with SBS Law...
-

Law Offices of Howard G. Smith Encourages Pentair plc (PNR) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) common stock between April 28, 2026 and July 14, 2026, inclusive (the “Class Period”). Pentair plc investors have until October 2, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PENTAIR PLC (PNR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN...
-

PNR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Pentair plc Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Aaron Walters v. , et al1:26-cv-06632, on behalf of persons and entities that purchased or otherwise acquired Pentair plc (“Pentair” or the “Company”) (NASDAQ: PNR) securities between April 28, 2026 and July 14, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sect...
-

شركة NIQ تعود إلى معرض IFA 2026 لقيادة الحوارات الصناعية بشأن النمو والابتكار والذكاء الاصطناعي وتحول سلوك المستهلكين

برلين--(BUSINESS WIRE)---- بصفتها الشريك الرسمي العالمي للرؤى في IFA Berlin 2026، ستواصل NIQ (بورصة نيويورك: NIQ) أداء دور رائد في صياغة النقاشات الصناعية، عن طريق الجمع بين البيانات والذكاء المدعوم بالذكاء الاصطناعي والرؤى البشرية لتسليط الضوء على القوى التي تعيد تشكيل النمو والابتكار وسلوك المستهلكين، ومن خلال كلمات رئيسية تلقيها القيادات التنفيذية وجلسات نقاشية وذكاء السوق الحصري، ومشاركات إستراتيجية مع العملاء (بما في ذلك المشاركة في قمة قادة قطاع التجزئة في IFA، والنسخة الرابعة من NIQ Busin...
-

Western Union Announces $0.235 Quarterly Dividend

DENVER--(BUSINESS WIRE)--The Western Union Company (NYSE: WU) announced today that its board of directors declared a quarterly cash dividend of $0.235 per common share, payable September 30, 2026, to stockholders of record at the close of business on September 16, 2026.About Western UnionThe Western Union Company (NYSE: WU) is committed to helping people around the world who aspire to build financial futures for themselves, their loved ones and their communities. Our leading cross-border, cross-...
-

HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operat...
-

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX).If you currently own shares of TransMedics Group stock, please visit the firm’s website at https://rosenlegal.com/cases/transmedics-group-inc/join for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com...